Seema S. Khemalapure
Seema S. Khemalapure publishes mostly in Organic Chemistry, Electronic, Optical and Magnetic Materials and Spectroscopy, on topics such as Nonlinear Optical Materials Research, Synthesis and biological activity and Free Radicals and Antioxidants.
- World rank
- #3,612,944 of 7,710,434 ranked researchers
- Rank in India
- #81,569 of 280,097
- Works
- 19
- Citations
- 537
- Citations per work
- 28.3
What does Seema S. Khemalapure research?
Seema S. Khemalapure's work is mostly in Chemistry (58%), Materials Science (27%), Medicine (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences1685.5%
- Chemistry1158.2%
- Materials Science527.3%
- Life Sciences17.2%
- Health Sciences15.5%
- Medicine15.5%
- 1Organic Chemistry53% of their works
- 2Electronic, Optical and Magnetic Materials27% of their works
- 3Spectroscopy6% of their works
- 4Oncology6% of their works
- 5Toxicology4% of their works
- 6Animal Science and Zoology4% of their works
Research topics
- Nonlinear Optical Materials Research
- Synthesis and biological activity
- Free Radicals and Antioxidants
- Synthesis and Characterization of Heterocyclic Compounds
- Structural and Chemical Analysis of Organic and Inorganic Compounds
- Metal complexes synthesis and properties
- Bioactive Compounds and Antitumor Agents
- Chemical synthesis and pharmacological studies
Which keywords describe Seema S. Khemalapure's research?
The keywords of their largest research topics: Anticancer Agents, Computational Chemistry, Nonlinear Optical Materials, Heterocyclic Compounds, Medicinal Chemistry, Synthesis, Antimicrobial and Heterocycles.
- Quinones
- Heterocyclic Chemistry
- Platinum-Based Drugs
- Cisplatin Resistance
- Anticancer
- Phenolic Compounds
- Heterocycles
- Synthesis
- Heterocyclic Compounds
- Computational Chemistry
- Anticancer Agents
- Nonlinear Optical Materials
- Medicinal Chemistry
- Antimicrobial
- Antioxidant
- Cycloaddition Reactions
- Triazines
- Oxadiazoles
- Thiadiazoles
- Properties
- Toxicology
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Anticancer Agents173 topics
- Computational Chemistry141 topic
- Nonlinear Optical Materials141 topic
- Heterocyclic Compounds121 topic
- Medicinal Chemistry121 topic
- Synthesis93 topics
- Antimicrobial72 topics
- Heterocycles72 topics
- Antioxidant61 topic
- Phenolic Compounds61 topic
- Cycloaddition Reactions52 topics
- Anticancer41 topic
- Triazines41 topic
- Cisplatin Resistance31 topic
- Oxadiazoles31 topic
- Platinum-Based Drugs31 topic
- Thiadiazoles31 topic
- Heterocyclic Chemistry21 topic
- Properties21 topic
- Quinones21 topic
- Toxicology21 topic
Where does Seema S. Khemalapure work?
Seema S. Khemalapure's main affiliation in the publication record is KLE Technological University, India.
How many publications and citations does Seema S. Khemalapure have?
OpenAlex counts 19 works and 537 citations for Seema S. Khemalapure, an h-index of 13, ranking #3,612,944 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Seema S. Khemalapure. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.